13 results on '"Ambrosi, Xavier"'
Search Results
2. Intravenous Milrinone for Cerebral Vasospasm in Subarachnoid Hemorrhage: The MILRISPASM Controlled Before–After Study
- Author
-
Lakhal, Karim, Hivert, Antoine, Alexandre, Pierre-Louis, Fresco, Marion, Robert-Edan, Vincent, Rodie-Talbere, Pierre-André, Ambrosi, Xavier, Bourcier, Romain, Rozec, Bertrand, and Cadiet, Julien
- Published
- 2021
- Full Text
- View/download PDF
3. Prevalence and risk factors of the use of physical restraint and impact of a decision support tool: A before‐and‐after study.
- Author
-
Dauvergne, Jérôme E., Ferey, Kim, Croizard, Véronique, Chauvin, Morgan, Mainguy, Nolwenn, Mathelier, Noeline, Jehanno, Anaëlle, Maugars, Nadège, Badre, Gaëtan, Maze, Françoise, Chartier, Marie, Vastral, Servane, Epain, Graziella, Baudiniere, Lucie, Ronceray, Mathilde, Lebidan, Mathias, Flattres, Delphine, Ambrosi, Xavier, Jan, Marie, and Bigot, Sébastien
- Subjects
RISK assessment ,CROSS-sectional method ,HUMAN services programs ,INTENSIVE care nursing ,T-test (Statistics) ,QUALITATIVE research ,SCIENTIFIC observation ,HOSPITAL care ,SEX distribution ,FISHER exact test ,LOGISTIC regression analysis ,NURSE-patient ratio ,RESTRAINT of patients ,DECISION making ,CATASTROPHIC illness ,MULTIVARIATE analysis ,NURSING ,AGE distribution ,DISEASE prevalence ,QUANTITATIVE research ,MANN Whitney U Test ,CHI-squared test ,MEDICAL device removal ,AGITATION (Psychology) ,PRE-tests & post-tests ,ODDS ratio ,INTENSIVE care units ,CATHETERS ,RESEARCH ,ARTIFICIAL respiration ,STATISTICS ,CONFIDENCE intervals ,COMPARATIVE studies - Abstract
Background: Physical restraint is frequently used in intensive care units to prevent patients' life‐threatening removal of indwelling devices. In France, their use is poorly studied. Therefore, to evaluate the need for physical restraint, we have designed and implemented a decision support tool. Aims: Besides describing the prevalence of physical restraint use, this study aimed to assess whether the implementation of a nursing decision support tool had an impact on restraint use and to identify the factors associated with this use. Study Design: A large observational, multicentre study with a repeated one‐day point prevalence design was conducted. All adult patients hospitalized in intensive care units were eligible for this study. Two study periods were planned: before (control period) and after (intervention period) the deployment of the decision support tool and staff training. A multilevel model was performed to consider the centre effect. Results: During the control period, 786 patients were included, and 510 were in the intervention period. The prevalence of physical restraint was 28% (95% CI: 25.1%–31.4%) and 25% (95% CI: 21.5%–29.1%) respectively (χ2 = 1.35; p =.24). Restraint was applied by the nurse and/or nurse assistant in 96% of cases in both periods, mainly to wrists (89% vs. 83%, p =.14). The patient‐to‐nurse ratio was significantly lower in the intervention period (1:3.0 ± 1 vs. 1:2.7 ± 0.7, p <.001). In multivariable analysis, mechanical ventilation was associated with physical restraint (aOR [95% CI] = 6.0 [3.5–10.2]). Conclusion: The prevalence of physical restraint use in France was lower than expected. In our study, the decision support tool did not substantially impact physical restraint use. Hence, the decision support tool would deserve to be assessed in a randomized controlled trial. Relevance to Clinical Practice: The decision to physically restrain a patient could be protocolised and managed by critical care nurses. A regular evaluation of the level of sedation could allow the most deeply sedated patients to be exempted from physical restraint. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Intravenous Milrinone for Cerebral Vasospasm: Here Comes the Sun?
- Author
-
Lakhal, Karim, Robert-Edan, Vincent, Rodie-Talbere, Pierre-André, Ambrosi, Xavier, and Fresco, Marion
- Published
- 2022
- Full Text
- View/download PDF
5. Transcranial Doppler in the Diagnosis of Cerebral Vasospasm: A Call for a Dynamic Approach
- Author
-
Lakhal, Karim, Robert-Edan, Vincent, Fresco, Marion, Ambrosi, Xavier, Riem, Romuald, Rodie-Talbere, Pierre-André, Marest, Delphine, Cinotti, Raphaël, and Rozec, Bertrand
- Published
- 2019
- Full Text
- View/download PDF
6. Immunotherapy With Antiprogrammed Cell Death 1 Antibody Improves Outcome in a Mouse Model of Spinal Cord Injury Followed by Staphylococcus aureus Pneumonia
- Author
-
Ruggeri, Tiphaine, Jacqueline, Cédric, Ambrosi, Xavier, Broquet, Alexis, Desfrançois, Juliette, Roquilly, Antoine, Altare, Frédéric, and Asehnoune, Karim
- Published
- 2019
- Full Text
- View/download PDF
7. Natural history of cardiac function in Duchenne and Becker muscular dystrophies on home mechanical ventilation
- Author
-
Fayssoil, Abdallah, Ogna, Adam, Chaffaut, Cendrine, Lamothe, Laure, Ambrosi, Xavier, Nardi, Olivier, Prigent, Helene, Clair, Bernard, Lofaso, Frederic, Chevret, Sylvie, Orlikowski, David, and Annane, Djillali
- Published
- 2018
- Full Text
- View/download PDF
8. Intraoperative transfusion practices in Europe
- Author
-
Meier, J., Filipescu, D., Kozek-Langenecker, S., Llau Pitarch, J., Mallett, S., Martus, P., Matot, I., Accurso, Giuseppe, Ahrens, Norbert, Akan, Mert, Åkeröy, Kristin, Aksoy, Omur, Alanoğlu, Zekeriyye, Alfredo, Merten, Alkis, Neslihan, Almeida, Valentina, Alousi, Mohammed, Alves, Claudia, Amaral, Joana, Ambrosi, Xavier, Ana, Izquierdo, Anastase, Denisa, Andersson, Mona, Andreou, Antonis, Anthopoulos, Georgios, Apanaviciute, Daiva, Arbelaez, Alejandro, Arcade, Anne-Laure, Arion-Balescu, Carmen, Arun, Oguzhan, Azenha, Marta, Bacalbasa, Nicolae, Baeten, Wannes, Balandin, Alina, Barquero López, Marta, Barsan, Victoria, Bascuas, Begona, Basora, Misericordia, Baumann, Holger, Bayer, Andreas, Bell, Andrea, Belmonte Cuenca, Julio, Bengisun, Zuleyha Kazak, Bento, Carlos, Beran, Maud, Bermudez Lopez, Maria, Bernardino, Ana, Berthelsen, Kasper Gymoese, Bigat, Zekiye, Bilshiene, Diana, Bilska, Marcela, Bisbe Vives, Elvira, Biscioni, Tamara, Björn, Heyse, Blom, Tommi, Bogdan Prodan, Alexandru, Bogdanovic Dvorscak, Matea, Boisson, Matthieu, Bolten, Jens, Bona, Francesco, Borg, Francis, Boros, Cristian, Borys, Michał, Boveroux, Pierre, Boztug Uz, Neval, Brettner, Florian, Brisard, Laurent, Britta, De Waal, Browne, Gail, Budow, Kristin, Buerkle, Hartmut, Buggy, Donal, Cain, Alistair, Calancea, Esenia, Calarasu, Florenta, Calder, Verity, Camci, Ali Emre, Campiglia, Laura, Campos, Beatriz, Camps, Angela, Carlos, Delgado, Carreira, Claudia, Carrilho, Alexandre, Carvalho, Peter, Cassinello, Concepcion, Cattan, Anat, Cenni, Leonardo, Cerny, Vladimir, Ceyda Meço, Başak, Chesov, Ion, Chishti, Ahmed, Chupin, Anne-Marie, Cikova, Andrea, Cindea, Iulia, Cintula, Daniel, Ciobanasu, Roxana, Clements, Deborah, Cobiletchi, Serghei, Coburn, Mark, Coghlan, Liz, Collyer, Thomas, Copotoiu, Sanda Maria, Copotoiu, Ruxandra, Corneci, Dan, Cortegiani, Andrea, Coskunfirat, O.Koray, Costea, Dan, Czuczwar, Mirosław, Davies, Katy, De Baerdemaeker, Luc, De Hert, Stefan, Debernardi, Felicino, Decagny, Sylvie, Deger Coskunfirat, Nesil, Diana, Toma, Diana, Gómez Martinez, Dias, Sandra, Dickinson, Matthew, Dobisova, Anna, Dragan, Anca, Droc, Gabriela, Duarte, Sonia, Dunk, Nigel, Ekelund, Kim, Ekmekçi, Perihan, Elena, Ciobanu, Ellimah, Tracey, Espie, Laura, Everett, Lynn, Ferguson, Andrew, Fernandes, Melissa, Fernández, J.A., Ferner, Marion, Ferreira, Daniel, Ferrie, Rosemary, Filipescu, Daniela, Flassikova, Zora, Fleischer, Andreas, Font, A., Galkova, Katarina, Garcia, Irene, Garner, Matt, Gasenkampf, Andrey, Gelmanas, Arunas, Gherghina, Viorel, Gilsanz, Fernando, Giokas, George, Goebel, Ulrich, Gomes, Piedade, Gonçalves Aguiar, José Manuel, Gonzalez Monzon, Veronica, Gottschalk, André, Gouraud, Jean-Pierre, Gramigni, Elena, Grintescu, Ioana, Grynyuk, Andriy, Grytsan, Alexey, Guasch, Emilia, Gustin, Denis, Hans, Grégory, Harazim, Hana, Hervig, Tore, Hidalgo, Francisco, Higham, Charley, Hirschauer, Nicola, Hoeft, Andreas, Innerhofer, Petra, Innerhofer-Pompernigg, Nicole, Jacobs, Stefan, Jakobs, Nicolas, Jamaer, Luc, James, Sarah, Jawad, Monir, Jesus, Joana, Jhanji, Shaman, Jipa Lavina, Nicoleta, Jokinen, Johanna, Jovanovic, Gordana, Jubera, Maria Pilar, Kahn, David, Karjagin, Juri, Kasnik, Darja, Katsanoulas, Konstantinos, Kelle, Hened, Kelleher, Mortimer, Kessler, Florian, Kirigin, Borana, Kiskira, Olga, Kivik, Peeter, Klimi, Pelagia, Klučka, Jozef, Koers, Lena, Kontrimaviciut, Egle, Koopman-van Gemert, A.W.M.M., Korfiotis, Demetrios, Kosinová, Martina, Koursoumi, Eygenia, Kozek Langenecker, Sibylle, Kranke, Peter, Kresic, Marina, Krobot, Renatas, Kropman, Lucienne, Kulikov, Alexander, Kvolik, Slavica, Kvrgic, Ivana, Kyttari, Aikaterini, Lagarto, Filipa, Lance, Marcus D., Laufenberg, Rita, Lauwick, Severine, Lecoq, Jean-Pierre, Leech, Leech, lidzborski, Lionel, Liliana, Henao, Linda, Filipe, Llau Pitarch, Juan Vicente, Lopes, Ana, Lopez, Luis, Lopez Alvarez, Alexo, Lorenzi, Irene, Lorre, Gilbert, Lucian, Horhota, Lupis, Tamara, Lupu, Mary Nicoleta, Macas, Andrius, Macedo, Ana, Maggi, Genaro, Mallett, Susan, Mallor, Thomas, Manoleli, Alexandra, Manolescu, Rely, Manrique, Susana, Maquoi, Isabelle, Marios-Konstantinos, Tasoulis, Markovic Bozic, Jasmina, Markus W., Hollmann, Marques, Margarida, Martinez, Raul, Martinez, Ever, Martínez, Esther, Martinho, Helder, Martins, Diogo, Martires, Emilia, Martus, Peter, Matias, Francisco, Matot, Idit, Mauff, Susanne, Meale, Paula, Meier, Jens, Merz, Hannah, Meybohm, Patrick, Militello, Maria Grazia, Mincu, Natalia, Miranda, Maria Lina, Mirea, Liliana, Moghildea, Victoria, Moise, Alida, Molano Diaz, Pablo, Moltó, Luís, Monedero, Pablo, Moral, Victoria, Moreira, Zélia, Moret, Enrique, Mulders, Freya, Munteanu, Anna Maria, Nadia Diana, Kinast, Nair, Ashok, Neskovic, Vojislava, Ninane, Vincent, Nitu, Denisa, Oberhofer, Dagmar, Odeberg-Wernerman, Suzanne, Oganjan, Juri, Omur, Dilek, Orallo Moran, Marian Angeles, Ozkardesler, Sevda, Pacasová, Rita, Paklar, Nataša, Pandazi, Ageliki, Papaspyros, Fotios, Paraskeuopoulos, Tilemachos, Parente, Suzana, Paunescu, Marilena Alina, Pavičić Šarić, Jadranka, Pereira, Filipa, Pereira, Elizabete, Pereira, Luciane, Perry, Chris, Petri, Attila, Petrovic, Uros, Pica, Silvia, Pinheiro, Filipe, Pinto, José, Pinto, Fernando, Piwowarczyk, Paweł, Platteau, Sofie, Poeira, Rita, Popescu, Ravzan, Popica, Georgian, Poredos, Peter, Prasser, Christopher, Preckel, Benedikt, Prospiech, Audrey, Pujol, Roger, Raimundo, Ana, Raineri, Santi Maurizio, Rakic, Dragana, Ramadan, Mohammed, Ramazanoğlu, Atilla, Rantis, Athanasios, Raquel, Ferrandis, Rätsep, Indrek, Real, Catia, Reikvam, Tore, Reis, Ligia, Rigal, Jean-Christophe, Rohner, Anne, Rokk, Alar, Roman Fernandez, Adriana, Rosenberger, Peter, Rossaint, Rolf, Rozec, Bertrand, Rudolph, Till, Saeed, Yousif, Safonov, Sergej, Saka, Esra, Samama, Charles Marc, Sánchez López, Óscar, Sanchez Perez, David, Sanchez Sanchez, Yvan Enrique, Sandeep, Varma, Sandu, Madalina Nina, Sanl, Suat, Saraiva, Alexandra, Scarlatescu, Ecaterina, Schiraldi, Renato, Schittek, Gregor, Schnitter, Bettina, Schuster, Michael, Seco, Carlos, Selvi, Onur, Senard, Marc, Serra, Sofia, Serrano, Helena, Shmigelsky, Alexander, Silva, Luisa, Simeson, Karen, Singh, Rita, Sipylaite, Jurate, Skitek, Kornel, Skok, Ira, Smékalová, Olga, Smirnova, Nadezda, Sofia, Machado, Soler Pedrola:, Maria, Söndergaard, Sören, Sõrmus, Alar, Sørvoll, Ingvild Hausberg, Soumelidis, Christos, Spindler Yesel, Alenka, Stefan, Mihai, Stevanovic, Ana, Stevikova, Jordana, Stivan, Sabina, Štourač, Petr, Striteska, Jana, Strys, Lydia, Suljevic, Ismet, Tania, Moreno, Tareco, Gloria, Tena, Beatriz, Theodoraki, Kassiani, Tifrea, Marius, Tikuisis, Renatas, Tolós, Raquel, Tomasi, Roland, Tomescu, Dana, Tomkute, Gabija, Tormos, Pilar, Trepenaitis, Darius, Troyan, Galina, Unic-Stojanovic, Dragana, Unterrainer, Axel, Uranjek, Jasna, Valsamidis, Dimitrios, van Dasselaar, Nick, Van Limmen, Jurgen, van Noord, Peter, van Poorten, J.F., Vanderlaenen, Margot, Varela Garcia, Olalla, Velasco, Ana, Veljovic, Milic, Vera Bella, Jorge, Vercauteren, Marcel, Verdouw, Bas, Verenkin, Vladimir, Veselovsky, Tomas, Vieira, Helena, Villar, Tania, Visnja, Ikic, Voje, Minca, von Dossow-Hanfstingl, Vera, Von Langen, Daniel, Vorotyntsev, Sergiy, Vujanovič, Vojislav, Vukovic, Rade, Watt, Philip, Werner, Eva, Wernerman, Jan, Wittmann, Maria, Wright, Margaret, Wunder, Christian, Wyffels, Piet, Yakymenko, Yevgen, Yldrm, Çiğdem, Ylmaz, Hakan, Zacharowski, Kai, Záhorec, Roman, Zarif, Maged, Zielinska-Skitek, Ewa, and Zsisku, Lajos
- Published
- 2016
- Full Text
- View/download PDF
9. Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease.
- Author
-
Kervella D, Braud P, Garandeau C, Phelizot C, Ambrosi X, Blancho G, Hourmant M, and Figueres L
- Subjects
- Humans, BNT162 Vaccine, SARS-CoV-2, Patients, Immunity, Humoral, COVID-19 Vaccines, COVID-19 prevention & control
- Published
- 2021
- Full Text
- View/download PDF
10. High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related Staphylococcus aureus Ventriculitis.
- Author
-
Grégoire M, Gaborit B, Deschanvres C, Lecomte R, Deslandes G, Dailly É, Ambrosi X, Bellouard R, Asseray N, Lakhal K, and Boutoille D
- Subjects
- Adult, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Cefazolin administration & dosage, Cerebral Ventriculitis microbiology, Humans, Meningitis drug therapy, Meningitis microbiology, Microbial Sensitivity Tests, Staphylococcal Infections drug therapy, Staphylococcal Infections microbiology, Staphylococcus aureus drug effects, Cefazolin therapeutic use, Cerebral Ventriculitis drug therapy, Staphylococcus aureus pathogenicity
- Abstract
A patient received continuous infusion of cefazolin 10 g then 8 g daily for an external ventricular drainage-related methicillin-susceptible Staphylococcus aureus (MSSA) ventriculitis. Median free concentrations in the cerebrospinal fluid were 11.9 and 6.1 mg/liter after 10- and 8-g doses, respectively. Free concentrations in the cerebrospinal fluid were always above the MIC usually displayed by methicillin-susceptible Staphylococcus aureus (MSSA) isolates. These results support the use of high-dose cefazolin to achieve sufficient meningeal concentrations., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
11. Comparison of ventilator-integrated end-tidal CO2 and transcutaneous CO2 monitoring in home-ventilated neuromuscular patients.
- Author
-
Orlikowski D, Prigent H, Ambrosi X, Vaugier I, Pottier S, Annane D, Lofaso F, and Ogna A
- Subjects
- Adult, Capnography methods, Female, France epidemiology, Humans, Male, Middle Aged, Monitoring, Physiologic methods, Neuromuscular Diseases physiopathology, Blood Gas Analysis methods, Blood Gas Monitoring, Transcutaneous methods, Carbon Dioxide blood, Neuromuscular Diseases metabolism, Respiration, Artificial methods, Tidal Volume physiology
- Abstract
Background: Non-invasive transcutaneous capnometry (TcCO2) is used to assess the home ventilation's efficiency. Recently, end-tidal CO2 (ETCO2) sensors have been integrated in life-support home ventilators. The purpose of this study was to compare the ventilator-integrated ETCO2 with TcCO2, in home-ventilated neuromuscular disease patients., Methods: ETCO2 and TcCO2 were simultaneously measured during one night in 28 patients. Daytime blood gases were drawn on the following morning to measure arterial PCO2 (PaCO2)., Results: Compared to PaCO2 values, both ETCO2 and TcCO2 showed a small bias (-0.1 mmHg and 0.6 mmHg, respectively) and a similar critical difference (6.8 mmHg and 7.3 mmHg, respectively). We found a good correlation between ETCO2 and TcCO2, both considering the mean nocturnal PCO2 (r = 0.897, p < 0.001; bias -1.1 [- 9.0; 6.9] mmHg) and the maximal PCO2 value over the night (r = 0.905, p < 0.001; bias 3.1 [-4.5; 10.8] mmHg). The concordance of the two techniques in detecting overnight PCO2 fluctuations was high, with r = 0.919 (p < 0.001) for the time spent with PCO2 >45 mmHg and r = 0.943 (p < 0.001) for the time with PCO2 >50 mmHg., Conclusions: The ventilator-integrated end-tidal CO2 monitoring is as reliable as the currently used transcutaneous measurement, resulting to be a valuable proxy of the overnight PCO2 evolution. This result opens the possibility of a simplification in the monitoring of home ventilated patients, since ETCO2 measurement can be performed directly at home, with a low additional cost. However, the accuracy of both these measurement techniques is not sufficient to replace blood gases, which remain the reference examination. ClinicalTrials.gov registration:NCT02068911., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
12. Nontraumatic coma in adults and children
- Author
-
Ambrosi X, Sharshar T, and Annane D
- Subjects
- Adult, Child, Humans, Prognosis, Coma
- Abstract
Competing Interests: X. Ambrosi, T. Sharshar et D. Annane déclarent n’avoir aucun lien d’intérêts.
- Published
- 2016
13. Emerging drugs for the treatment of sepsis.
- Author
-
Heming N, Lamothe L, Ambrosi X, and Annane D
- Subjects
- Animals, Anti-Bacterial Agents therapeutic use, Antibodies, Monoclonal administration & dosage, Hemoperfusion methods, Humans, Immunologic Factors therapeutic use, Sepsis physiopathology, Drug Design, Sepsis drug therapy
- Abstract
Introduction: The incidence of sepsis, the systemic inflammatory response of the host to an infectious insult, has steadily increased over past decades. This trend is expected to continue. Sepsis is a leading cause of death and disability worldwide. Treatment relies on antibiotics associated to source control and supportive care. Major progress has been made in the understanding and overall management of sepsis. However, there is no specific treatment for sepsis., Areas Covered: We searched PubMed and the ClinicalTrials.gov site for English language reports of phase II and III clinical trials pertaining to the field of sepsis. The current review provides a summary of promising candidate treatments for sepsis. We broadly separated candidate drugs into three distinct categories: Blood purification techniques, immunomodulatory drugs and treatments targeting other systems including the heart, the endothelium or coagulation., Expert Opinion: Efforts to identify an efficient treatment for sepsis are hampered by the broad definition of the syndrome associated with major heterogeneity between patients affected by sepsis. The characterization of homogeneous groups of patients, through biological or clinical markers is unfortunately lacking. Current research remains active. Candidate drugs for sepsis include hemoperfusion with polymyxin B coated fibre devices, modulation of the immune system with treatments such as hydrocortisone, intravenous immunoglobulins, mesenchymal stem cells, GM-CSF or interferon gamma. Candidate drugs acting on the cardiovascular system include short acting beta 1 blockers, levosimendan or selepressin. Finally, promising strategies, involving monoclonal antibodies or protein antagonists, which selectively inhibit bacterial virulence factors are being assessed at the bedside. A much awaited and needed specific treatment for sepsis will hopefully soon emerge.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.